Active Ingredient(s): Kunecatechins
FDA Approved: * October 31, 2006
Pharm Company: * MEDIGENE
Category: Sexual Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Veregen Overview

Genital warts are a sexually transmitted infection caused by certain types of human papillomavirus (HPV).[4] They are generally pink in color and project out from the surface of the skin.[1] Usually they cause few symptoms, but can occasionally be painful.[3] Typically they appear one to eight months following exposure.[2] Warts are the most easily recognized symptom of genital HPV infection.[2] HPV types 6 and 11...

Read more Veregen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Veregen Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Ointment: 15%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Veregen: (1 result)

Sorted by National Drug Code
  • 10337-450 Veregen 150 mg/g Topical Ointment by Pharmaderm a Division of Fougera Pharmaceuticals Inc.

Other drugs which contain Kunecatechins or a similar ingredient: (1 result)